Yesterday, Alphabet aka Google (Nasdaq: GOOG) announced its first quarter results that soared past market expectations. The stock climbed 5% in the after-hours trading session post results announcement.
This week, Alphabet aka Google (Nasdaq: GOOG) reported a mixed fourth quarter. It missed the revenue estimate as the cloud business growth was less than the previous quarter.
According to a recent report, the global data privacy software market size is estimated to grow at 36% CAGR to reach $17.2 billion market by 2032 from $3.84 billion in 2024. The significant growth in the industry is expected to be driven by the continuing adoption of IoT devices along with the added power of
Lexington-based Valo Health is one of the pioneering players in the AI-drug discovery market. Set up in 2019 as part of Flagship Pioneering’s initiatives, Valo has had quite a roller coaster ride so far.
The Small Molecule Drug Discovery Market is estimated to grow at 9% CAGR from $74.08 billion in 2024 to reach $175.41 billion by 2034. San Francisco-based Atomwise is one player that is making use of its AI capabilities to make a mark in the industry.
Communication Platform as a Service (CPaaS) player Twilio (NYSE: TWLO) recently announced its third quarter results that outpaced market expectations. The improved outlook and the strong performance helped take the stock 10% higher in the after-hours trading session.
Amazon (NASDAQ: AMZN) recently announced its third-quarter results that beat market expectations driven by its growth in its cloud and advertising businesses.
NVIDIA (NASDAQ: NVDA) last week reported its second quarter results which beat all estimates. However, after three straight quarters of revenue growth above 200%, its growth of 122% seems a tad disappointing and its shares fell 8% in extended trading. This is a slight pullback after an astronomical rally following the AI boom. Its stock